PriceTargets.com logo

RHÖN-KLINIKUM Aktiengesellschaft - RHK Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: €0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€14.40 As of 01/27/2023 01:00 AM ET
▼ -0.2 (-1.37%)

This chart shows the closing price for RHK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RHÖN-KLINIKUM Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RHK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RHK

Analyst Price Target is €0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for RHÖN-KLINIKUM Aktiengesellschaft in the last 3 months. The average price target is €0.00, with a high forecast of €0.00 and a low forecast of €10,000,000.00. The average price target represents a -100.00% upside from the last price of €14.40.

This chart shows the closing price for RHK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in RHÖN-KLINIKUM Aktiengesellschaft. This rating has held steady since June 2021, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/29/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/8/2020Independent ResearchSet TargetSell€18.00
3/27/2020Independent ResearchSet TargetNeutral€18.00
3/5/2020Independent ResearchSet TargetSell€18.00
3/3/2020Berenberg BankSet TargetNeutral€18.00
3/2/2020Kepler Capital MarketsSet TargetNeutral€18.00
2/26/2020Independent ResearchSet TargetNeutral€17.60
2/24/2020Kepler Capital MarketsSet TargetSell€14.30
2/21/2020Berenberg BankSet TargetNeutral€19.75
12/2/2019Berenberg BankSet TargetNeutral€19.75
11/21/2019Independent ResearchSet TargetNeutral€19.80
11/19/2019Credit Suisse GroupSet TargetSell€16.50
11/13/2019Credit Suisse GroupSet TargetSell€16.50
8/5/2019Independent ResearchSet TargetNeutral€25.50
8/5/2019Credit Suisse GroupSet TargetSell€16.50
7/30/2019Berenberg BankSet TargetNeutral€26.20
5/10/2019Independent ResearchSet TargetNeutral€27.00
5/10/2019Credit Suisse GroupSet TargetSell€16.50
5/3/2019Warburg ResearchSet TargetNeutral€25.50
5/3/2019Berenberg BankSet TargetNeutral€26.20
4/11/2019Kepler Capital MarketsSet TargetSell€19.00
4/11/2019Warburg ResearchSet TargetNeutral€25.50
4/11/2019Berenberg BankSet TargetNeutral€23.50
4/1/2019Kepler Capital MarketsSet TargetSell€19.00
4/1/2019Independent ResearchSet TargetNeutral€26.00
2/26/2019Independent ResearchSet TargetNeutral€25.00
2/25/2019Warburg ResearchSet TargetNeutral€25.50
2/19/2019Warburg ResearchSet TargetNeutral€25.50
1/23/2019Credit Suisse GroupSet TargetSell€17.00
1/11/2019Warburg ResearchSet TargetNeutral€25.50
1/9/2019Kepler Capital MarketsSet TargetSell€19.00
11/16/2018CommerzbankSet TargetSell€19.00
11/14/2018Berenberg BankSet TargetNeutral€23.50
11/13/2018Independent ResearchSet TargetNeutral€24.00
11/12/2018CfraSet TargetSell€22.00
11/9/2018CommerzbankSet TargetNeutral€25.00
11/9/2018Warburg ResearchSet TargetNeutral€25.20
9/17/2018Warburg ResearchSet TargetNeutral€25.20
8/8/2018Independent ResearchSet TargetNeutral€26.00
8/6/2018Berenberg BankSet TargetNeutral€27.75
8/6/2018Credit Suisse GroupSet TargetSell€19.00
8/3/2018CfraSet TargetSell€25.00
8/2/2018Kepler Capital MarketsSet TargetSell€22.00
8/2/2018Warburg ResearchSet TargetNeutral€25.20
8/2/2018CommerzbankSet TargetNeutral€25.00
5/14/2018Berenberg BankSet TargetNeutral€29.15
5/8/2018Independent ResearchSet TargetNeutral€29.00
5/4/2018Warburg ResearchSet TargetNeutral€25.20
5/4/2018Kepler Capital MarketsSet TargetSell€22.00
4/4/2018Warburg ResearchSet TargetNeutral€25.20
4/3/2018Independent ResearchSet TargetNeutral€29.00
3/29/2018Warburg ResearchSet TargetNeutral€25.20
3/20/2018Warburg ResearchSet TargetNeutral€25.20
3/8/2018Credit Suisse GroupSet TargetSell€23.50
2/27/2018CfraSet TargetSell€25.00
2/23/2018Berenberg BankSet TargetNeutral€29.15
2/14/2018Warburg ResearchSet TargetSell€25.00
(Data available from 1/29/2018 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/3/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/2/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/30/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/29/2023

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
RHÖN-KLINIKUM Aktiengesellschaft logo
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.
Read More

Today's Range

Now: €14.40
Low: €14.10
High: €14.60

50 Day Range

MA: €15.19
Low: €14.40
High: €15.65

52 Week Range

Now: €14.40
Low: €13.00
High: €16.20

Volume

7,107 shs

Average Volume

43,281 shs

Market Capitalization

$963.91 million

P/E Ratio

32.73

Dividend Yield

1.60%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of RHÖN-KLINIKUM Aktiengesellschaft?

The following sell-side analysts have issued research reports on RHÖN-KLINIKUM Aktiengesellschaft in the last twelve months:
View the latest analyst ratings for RHK.

What is the current price target for RHÖN-KLINIKUM Aktiengesellschaft?

0 Wall Street analysts have set twelve-month price targets for RHÖN-KLINIKUM Aktiengesellschaft in the last year. has the lowest price target set, forecasting a price of €10,000,000.00 for RHÖN-KLINIKUM Aktiengesellschaft in the next year.
View the latest price targets for RHK.

What is the current consensus analyst rating for RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RHK.

What other companies compete with RHÖN-KLINIKUM Aktiengesellschaft?

Other companies that are similar to RHÖN-KLINIKUM Aktiengesellschaft include Stratec, Biotest Aktiengesellschaft, MorphoSys, Drägerwerk AG & Co. KGaA and Gerresheimer. Learn More about companies similar to RHÖN-KLINIKUM Aktiengesellschaft.

How do I contact RHÖN-KLINIKUM Aktiengesellschaft's investor relations team?

RHÖN-KLINIKUM Aktiengesellschaft's physical mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company's listed phone number is +49-9-771650. The official website for RHÖN-KLINIKUM Aktiengesellschaft is www.rhoen-klinikum-ag.com. Learn More about contacing RHÖN-KLINIKUM Aktiengesellschaft investor relations.